• Home
  • Search Results

Search Results

Young Adult (18-34)
2364 studies match your search
Coming Soon

CHS-388-202- A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab

This research is being done in participants who have Hepatocellular Carcinoma (HCC), also referred to as Liver Cancer, to evaluate how 3 drugs work in combination, and which dose is the best to treat your disease. The 3 drugs are casdozokitug (casdozo-key-tug), toripalimab (tor-i-pal-i- mab) and bevacizumab (bev-uh-siz-oo-mab). Toripalimab and bevacizumab have been approved by the Food and Drug Administration (FDA) to treat other cancers, but not Liver cancer. Casdozokitug has not been approved by the FDA to treat any cancers.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
  • Kidneys and Liver
Coming Soon

A Study of YL201 in Patients With Advanced Solid Tumors

This is a study of an investigational drug called YL201 as a possible treatment for advanced solid tumors. YL201 is thought to work by interrupting DNA replication in cancer cells, via focused delivery of the cytotoxic agent to the cancer cell. YL201 has shown some anti-cancer effects against cancer cells in the laboratory and in experimental animals. The main purpose of this study is to learn how safe the study drug and how well the study drug works.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Not currently enrolling

Young Adult Drinking Study

This study is assessing the usefulness of a text message based intervention to reduce excessive alcohol use among young adults ages 18-25. Participants will attend a Baseline Session over Zoom where they will complete a 25-minute survey and learn more about study procedures. Then, participants will receive daily prompts to their personal cellphone Wednesday-Sunday for 4 weeks. After the 4-week trial, participants will attend 1 focus group over Zoom to share their experiences in the study.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
100% Remote (online, phone, text)
Open

Mental Health Study

Is your child between the ages of 8 and 11? Was your child assigned female sex at birth? If so, you may be able to take part in a study to see how social experiences and puberty can affect the mental health of preteen girls. We want to help improve youth mental health support. Compensation provided.

Age & Gender
  • 8 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Behavior
  • Developmental
  • Glands and Hormones
  • and 6 more
Visit Location
100% Remote (online, phone, text)
Open

Memory and Aging Study

Are you right-handed? Are you between the ages 18 and 35 or 65 and 85? Are you interested in testing your memory? If so, you may be able to take part in a study on how younger and older adults learn and remember objects. You can help us learn more about how memory works in adults! Compensation provided.

Age & Gender
  • 18 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Brain, Head, Nervous System
  • Opinions and Perceptions
  • and 2 more
Coming Soon

Combination of XL092 and Cemiplimab in Anaplastic Thyroid Cancer

The purpose of this study is to look at the effectiveness of giving cemiplimab and XL092 before and after surgery for Anaplastic Thyroid Cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Thyroid and Other Gland/Endocrine)
Coming Soon

Dendritic Cell Immunotherapy for Treatment of Adult GBM

The purpose of this research is to see if an experimental vaccine, which is created from your tumor tissue and dendritic cells isolated from your blood, can be an effective therapy when given after your standard treatment of surgery, chemotherapy, and radiation.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System)
Open

Breakfree-SLE

Have you been diagnosed with Lupus or Lupus Nephritis? A single infusion of CD19-directed CAR T therapy may help reset your immune system by targeting harmful B cells, potentially leading to long-term disease control without ongoing treatment.

Age & Gender
  • 16 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Immune System/Infections
  • Women's Health
  • and 2 more
Open

How Knee Joint Movement Affects Cartilage Strain and Arthritis Risk

Did you recently have an ACLR? Are you aware of your increase chances of developing knee osteoarthritis? If so, please participate in our study analyzing how knee joint movements are linked to cartilage strain to help prevent knee osteoarthritis. Compensation provided.

Age & Gender
  • 18 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Healthy Volunteer or General Population
  • Wellness and Lifestyle
  • and 2 more
Not currently enrolling

Depression Treatment Study

In this study, we want to find out if a single therapy session that shows people how to deal with depression is effective.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Mental and Emotional Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research